News Headlines Article

Gilead accused of funneling kickbacks to providers to boost sales
Modern Healthcare

The drugmaker Gilead Sciences has been hit with a whistle-blower suit accusing it of paying healthcare providers, government agencies and others organizations to boost sales of its hepatitis and HIV drugs.

In an unsealed False Claims Act case in California federal court, a whistle-blower claimed Gilead’s Frontlines of Communities in the United States program, which partners with other institutions to facilitate hepatitis and HIV screenings, resulted in billions of dollars in excess government spending.